Clinical Trials Browser

Recurrence × Fulvestrant × Gynecologic × Clear all

NCT00334295 2012-07-31

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Phase 2 Completed

35 enrolled 9 charts

Recurrence, Endometrial Neoplasms